Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Topical Tyrosine Versus Topical 5-Fluorouracil With Fractional Erbium YAG Laser in Focal Vitiligo
NCT07742982Phase 1Recruiting
- Sponsor
- Aswan University
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 1, randomised trial of tyrosine in focal vitiligo (2 arms), sponsored by Aswan University. Primary endpoint: Treatment of Focal Vitiligo at 1 year. Started Jun 2026; status: recruiting.
02
Drugs
tyrosine
03
Conditions
focal vitiligo
Beyond the preview
Go deeper on NCT07742982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07742982.